TERREMOTO BIOSCIENCES
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
TERREMOTO BIOSCIENCES
Social Links:
Industry:
Biotechnology
Founded:
2021-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.terremotobio.com
Total Employee:
11+
Status:
Active
Total Funding:
250 M USD
Technology used in webpage:
SPF Amazon Cloudflare Hosting Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Amazon Virginia Region Amazon Route 53 Slack Zendesk
Similar Organizations
Aspen Neuroscience
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.
AUM LifeTech
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Integral Molecular
Integral Molecular is a research-driven biotechnology company creating innovative technologies and a pipeline of therapeutic antibodies
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cormorant Capital
Cormorant Capital investment in Series B - Terremoto Biosciences
EcoR1 Capital
EcoR1 Capital investment in Series B - Terremoto Biosciences
Novo Holdings
Novo Holdings investment in Series B - Terremoto Biosciences
Third Rock Ventures
Third Rock Ventures investment in Series B - Terremoto Biosciences
OrbiMed
OrbiMed investment in Series B - Terremoto Biosciences
Third Rock Ventures
Third Rock Ventures investment in Series A - Terremoto Biosciences
OrbiMed
OrbiMed investment in Series A - Terremoto Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2024-07-25 | Terremoto Biosciences Appoints Charles Baum, M.D., Ph.D., as Chief Executive Officer |
Official Site Inspections
http://www.terremotobio.com Semrush global rank: 6.95 M Semrush visits lastest month: 968
Unable to get host informations!!!
More informations about "Terremoto Biosciences"
About - Terremoto
Sep 30, 2024 At Terremoto, we are breaking open the covalent drug universe with the power …See details»
Terremoto Biosciences - Crunchbase Company Profile …
Terremoto Biosciences may be growing as it has successfully closed a significant funding round. The company secured $175 million, which is indicative of …See details»
Careers | Terremoto
Many of our founding members and leadership team were the original pioneers in the emerging, game-changing field of covalent chemistry. We are looking for additional scientists and industry leaders who are similarly driven to explore …See details»
Terremoto Biosciences - LinkedIn
Terremoto Biosciences is a covalent drug discovery and development engine creating highly targeted, small molecule medicines with unmatched selectivity, potency and efficacy.See details»
Terremoto Biosciences - PitchBook
Terremoto Biosciences General Information Description. Developer of Drug delivery and discovery platform designed for small-molecule medicines. The company's platform features the ability to deliver medicines with optimized …See details»
Terremoto Biosciences - Products, Competitors, Financials, …
Jul 26, 2022 terremotobio.com. Overview & Products; Financials; People; Founded Year …See details»
Terremoto biosciences - Company info. interviews, news
Jan 12, 2024 10 Major Biotech Funding Rounds of 2023 Jan. 12, 2024 In 2023, the venture …See details»
Terremoto Biosciences - Funding, Financials, Valuation & Investors
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based …See details»
Terremoto Biosciences Launches With $75 Million Series A …
May 25, 2022 More information is available at www.terremotobio.com. Contacts. Media …See details»
Novo Holdings invests to advance highly targeted …
Nov 2, 2023 More information is available at www.terremotobio.com. About Novo Holdings A/S Novo Holdings is a holding and investment company that is responsible for managing the assets and the wealth of the Novo Nordisk …See details»
Terremoto Biosciences Appoints Charles Baum, M.D., Ph.D., as …
Jul 25, 2024 SOUTH SAN FRANCISCO, Calif., July 25, 2024--Terremoto Biosciences, a …See details»
Terremoto Biosciences Closes $175 Million Series B Financing
Terremoto is supported by leading investors including OrbiMed, Third Rock Ventures, EcoR1 …See details»
Terremoto Biosciences gets $75M to Develop Covalent Medicines
May 25, 2022 San Francisco-based Terremoto Biosciences launched with $75 million in …See details»
Terremoto Biosciences Launches With $75 Million Series A
May 25, 2022 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Terremoto …See details»
Terremoto Biosciences Closes $175 Million Series B Financing
Nov 2, 2023 Terremoto Biosciences, a biotechnology company developing highly targeted, …See details»
Terremoto Biosciences Launches With $75 Million Series A …
May 25, 2022 With fundamental advancements made by the founding team, Terremoto’s …See details»
Terremoto Biosciences Closes $175 Million Series B Financing
Terremoto Biosciences Closes $175 Million Series B FinancingSee details»
News - Terremoto
Jul 25, 2024 Terremoto Biosciences, a biotechnology company developing first- and best-in …See details»
Science - Terremoto
We use orthogonal approaches to tether molecules to proteins, similar to the methodology …See details»